MedPath

INSTYLLA INC.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

(HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds

Not Applicable
Recruiting
Conditions
Arterial Bleeding in Solid Organs and Peripheral Arteries
First Posted Date
2022-05-06
Last Posted Date
2024-12-17
Lead Sponsor
Instylla, Inc.
Target Recruit Count
118
Registration Number
NCT05364502
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Banner Health, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Memorial Health Services, Long Beach, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Stanford University, Stanford, California, United States

and more 19 locations

Instylla HES Hypervascular Tumor Pivotal Study

Not Applicable
Completed
Conditions
Hypervascular Tumors
Interventions
Device: Instylla HES
Other: TAE or cTACE
First Posted Date
2020-08-21
Last Posted Date
2024-12-16
Lead Sponsor
Instylla, Inc.
Target Recruit Count
150
Registration Number
NCT04523350
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Pennsylvania, Philadelphia, Pennsylvania, United States

๐Ÿ‡จ๐Ÿ‡ฆ

Mount Sinai, Toronto, Ontario, Canada

๐Ÿ‡บ๐Ÿ‡ธ

University of California, Irvine, Irvine, California, United States

and more 12 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath